A carregar...

ADVANCING THE MRD CONCEPT IN ACUTE MYELOID LEUKEMIA

The criteria to evaluate response to treatment in acute myeloid leukemia (AML) have changed little in the past sixty years. It is now possible to use higher sensitivity tools to measure residual disease burden in AML. Such minimal or measurable residual disease (MRD) measurements provide a deeper un...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Semin Hematol
Main Authors: Hokland, Peter, Ommen, Hans B., Mulé, Matthew P., Hourigan, Christopher S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4484880/
https://ncbi.nlm.nih.gov/pubmed/26111465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2015.04.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!